Feature Spectral combining diagnostics with targeted therapy in novel approach to septic shock Spectral Medical (TSX: EDT) is seeking to improve outcomes for millions of patients with life-threatening endotoxic septic shock (ESS), by combining its targeted diagnostic, Endotoxin Activity Assay (EAA), with its... November 12, 2024